Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Theodor Fehr is active.

Publication


Featured researches published by Theodor Fehr.


International Archives of Allergy and Immunology | 1988

Protein Kinase C Activators of the Teleocidin Family Decrease the IgE-Binding Capacity of Rat Basophilic Leukemia Cells

Claire Gavériaux; Theodor Fehr; Encarnita Montecino-Rodriguez; Jean-Jacques Sanglier; Francis Loor

The tumor promoters 12-O-tetradecanoylphorbol-13-acetate (TPA) and the teleocidins (TCDs) had similar inhibitory effects on IgE binding onto the membrane of rat basophilic leukemia (RBL)-2H3 cells. The level of expression of the functional IgE Fc receptor (Fc epsilon R), as measured by CELISA, was decreased up to a maximum of 60% within 5 min-1 h of treatment. This inhibition was obtained at concentrations of 0.1 microgram/ml for most TCDs, of 1 microgram/ml for TPA and of 20 micrograms/ml for one TCD (olivoretin A). These molecules also decreased the amount of cell-bound IgE detectable by CELISA on cells that had been coated with IgE prior to TCD treatment. When incubated with RBL-2H3 cells for 30 min-2 h, the TCDs and TPA stimulated serotonin release. Depending on their concentration, they had various effects on IgE-plus antigen-induced serotonin release. It is suggested that the down-regulation of IgE receptor expression by these tumor promoters is mediated through protein kinase C activation and phosphorylation of the Fc epsilon R.


The Journal of Antibiotics | 1999

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110

Jean-Jacques Sanglier; Valerie Quesniaux; Theodor Fehr; Hans Hofmann; Marion Mahnke; Klaus Memmert; Walter Schuler; Gerhard Zenke; Liliane Gschwind; Claudine Maurer; Wolfgang Schilling


The Journal of Antibiotics | 1999

Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties.

Theodor Fehr; Jörg Kallen; Lukas Oberer; Jean-Jacques Sanglier; Wolfgang Schilling


The Journal of Antibiotics | 1996

Antascomicins A, B, C, D, and E - Novel FKBP12 Binding Compounds from a Micromonospora Strain.

Theodor Fehr; Jean-Jacques Sanglier; Walter Schuler; Liliane Gschwind; Monique Ponelle; Wolfgang Schilling; Catherine Wloland


The Journal of Antibiotics | 1977

MUTALOMYCIN, A NEW POLYETHER ANTIBIOTIC TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION

Theodor Fehr; Hamilton D. King; Max Kuhn


Archive | 1994

Rapamycin-like macrolide and a new strain of streptomyces which produces it

Theodor Fehr; Jean-Jacques Sanglier; Walter Schuler


The Journal of Antibiotics | 1997

Cymbimicin A and B, Two Novel Cyclophilin-binding Structures Isolated from Actinomycetes.

Theodor Fehr; Valerie Quesniaux; Jean-Jacques Sanglier; Lukas Oberer; Liliane Gschwind; Monique Ponelle; Wolfgang Schilling; Susi Wehrli; Albert Enz; Gerhard Zenke; Walter Schuler


The Journal of Antibiotics | 1989

2-Epimutalomycin and 28-epimutalomycin, two new polyether antibiotics from Streptomyces mutabilis. Derivatization of mutalomycin and the structure elucidation of two minor metabolites.

Theodor Fehr; Max Kuhn; Hans-Rudolf Loosli; Monique Ponelle; Johann Jakob Boelsterli; Malcolm Douglas Walkinshaw


Archive | 1994

Macrolides as antagonists of macrophilin binding immunosuppressants

Theodor Fehr; Jean-Jacques Sanglier


The Journal of Antibiotics | 1979

Correction of the stereo structures of mutalomycin, noboritomycin A and noboritomycin B.

Theodor Fehr; Camilla Dr Keller-Juslen; Hamilton D. King; Hans-Rudolf Loosli; Max Kuhn; Albert Von Wartburg

Collaboration


Dive into the Theodor Fehr's collaboration.

Researchain Logo
Decentralizing Knowledge